- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Doximity Insider Sells $58,833 in Stock
Siddharth Sitaram, a Doximity insider, sold over 2,300 shares of the company's stock.
Mar. 13, 2026 at 2:20am by Ben Kaplan
Got story updates? Submit your updates here. ›
Doximity, Inc. (NASDAQ:DOCS) insider Siddharth Sitaram sold 2,319 shares of the company's stock on March 10th, 2026. The shares were sold at an average price of $25.37, resulting in a total transaction of $58,833.03. Following the sale, Sitaram still owns 84,132 shares in the company, valued at $2,134,428.84.
Why it matters
Insider selling can sometimes be a signal that an executive or major shareholder believes the stock is overvalued. However, individual stock sales do not necessarily indicate broader sentiment, as insiders may sell for a variety of personal financial reasons.
The details
Sitaram's sale represents a 2.68% decrease in his position. The transaction was disclosed in a filing with the SEC. Doximity is a healthcare technology company that operates a professional medical network for healthcare providers.
- The shares were sold on Tuesday, March 10th, 2026.
The players
Siddharth Sitaram
An insider at Doximity, Inc. who sold 2,319 shares of the company's stock.
Doximity, Inc.
A healthcare technology company that operates a professional medical network for healthcare providers.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
The takeaway
This insider sale is a relatively small transaction and does not necessarily indicate broader concerns about Doximity's outlook. Insider trading activity should be considered alongside other financial and operational data when evaluating a company's prospects.
San Francisco top stories
San Francisco events
Apr. 4, 2026
MJ (Touring)Apr. 4, 2026
Nimesh Patel: With All Due Disrespect




